Champions Oncology (CSBR) Reports Q4 Loss of $0.15/Share

July 27, 2017 4:27 PM EDT

Champions Oncology (NASDAQ: CSBR) reported Q4 EPS of ($0.15), versus ($0.24) reported last year. Revenue for the quarter came in at $3.72 million, versus $2.8 million reported last year.

For earnings history and earnings-related data on Champions Oncology (CSBR) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings, Guidance

Related Entities

Earnings